MELI
MercadoLibre, Inc.
MELI has the edge over NKE overall, supported by stronger modeled upside and stronger fundamentals.
NKE
NIKE, Inc.
NKE trails on the overall score without a compensating advantage in the available component scores.
MELI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Strong | |
| Stable |
MELI's revenue and cash flow are currently strong, and its profitability and balance sheet are stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
MELI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 33x | $1,475 | — |
| Current | 40x | $1,475 | — |
| Cheap | 50x | $1,874 | +27% |
| Fair | 75x | $2,798 | +90% |
| Expensive | 193x | $7,183 | +387% |
Historical ranges are pointers, not guarantees.
MELI has the edge over NKE in the historical PE scenario, which offers more potential upside but is not a forecast.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
MELI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MELI, but weaker profitability.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
MELI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $44.82 | +20% |
| Q3 2026 | $37.28 | -9% |
| Q2 2026 | $36.77 | -9.2% |
| Q1 2026 | $37.89 | -6.8% |
| Q4 2025 | $39.40 | +4.5% |
| Q3 2025 | $40.97 | +45% |
| Q2 2025 | $40.48 | +46% |
| Q1 2025 | $40.65 | +82% |
| Q4 2024 | $37.69 | +93% |
MELI has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
MELI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.8B | +45% |
| Q2 2026 | $10.2B | +50% |
| Q1 2026 | $8.8B | +49% |
| Q4 2025 | $8.8B | +45% |
| Q3 2025 | $7.4B | +39% |
| Q2 2025 | $6.8B | +34% |
| Q1 2025 | $5.9B | +37% |
| Q4 2024 | $6.1B | +42% |
MELI has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | -3.5 points |
| Q2 2026 | 6.7% | -5.4 points |
| Q1 2026 | 6.9% | -5.9 points |
| Q4 2025 | 10% | -3.4 points |
| Q3 2025 | 9.8% | -0.7 points |
| Q2 2025 | 12% | -2.2 points |
| Q1 2025 | 13% | +0.7 points |
| Q4 2024 | 14% | +7.9 points |
MELI's operating margin was 6.3% last quarter, down 3.5 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over MELI on profitability, with a higher operating margin.
MELI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.4B | -6% |
| Q2 2026 | $3.2B | +22% |
| Q1 2026 | $1.8B | +138% |
| Q4 2025 | $4.8B | +83% |
| Q3 2025 | $2.6B | +89% |
| Q2 2025 | $2.6B | +55% |
| Q1 2025 | $759M | -44% |
| Q4 2024 | $2.6B | +50% |
MELI has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
MELI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -195 shares |
| 1 year | 0% | -178 shares |
| 3 years | +1% | +488K shares |
| 5 years | +2.2% | +1.1M shares |
| Available history | +2% | +987K shares |
MELI has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $1M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $1M |
| Q1 2024 | — |
| Q4 2023 | — |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
MELI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.0x | Very low |
MELI's net debt is about 2.3 years of its operating earnings (EBITDA), up from 1.4 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over MELI on leverage, with a lower net debt burden relative to earnings.
MELI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.0 | Neutral |
| Stochastic | 6.5 | Oversold |
MELI's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
MELI PE vs Consumer Cyclical Sector
| Metric | MELI | Sector median | Relative |
|---|---|---|---|
| PE | 40x | 18x | 120% above |
| PE % | 0 | 47 | 47 pts below |
MELI is trading at 40x earnings, a 120% premium to the Consumer Cyclical sector's median of 18x.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over MELI on valuation relative to its sector.
MELI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,699.1 | 13% below |
| 20 week MA | $1,796.0 | 18% below |
| 50 week MA | $1,820.0 | 19% below |
| 100 week MA | $2,010.5 | 27% below |
| 200 week MA | $1,769.5 | 17% below |
MELI is in a downtrend: it's below all five of its weekly moving averages, and 17% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over MELI on trend strength, trading above more of its moving averages.
MELI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $599.2 | $1,690.5 | +182% |
| 2021 | $1,690.5 | $1,262.7 | -25% |
| 2022 | $1,262.7 | $878.3 | -30% |
| 2023 | $878.3 | $1,571.5 | +79% |
| 2024 | $1,571.5 | $1,725.5 | +9.8% |
| 2025 | $1,725.5 | $2,005.7 | +16% |
| 2026 YTD | $2,005.7 | $1,475.1 | -26% |
MELI has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.